Sera Prognostics Inc (SERA) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Sera Prognostics Inc   (NASDAQ: SERA)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Sera Prognostics Inc Profitability Comparisons

Select each Category to receive further Information




SERA Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) -66.67 % 42.76 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 28.57 % 43.26 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 44.06 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 1916.67 % 13.35 % 18.99 % 20.49 %
EBITDA Margin (Q2 TTM) -32620 % 14.81 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. --29899.46 % 15.12 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -33346.67 % 8.21 % 16.58 % 16.05 %
Operating Margin (Q2 TTM) -53282.86 % 8.63 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. --33171.39 % 8.63 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 6.41 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -34420 % 7.53 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 7.36 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -30463.33 % 5.07 % 8.15 % 11.42 %
Net Margin (Q2 TTM) -47475.71 % 5.6 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. - 5.18 % 6.08 % 10.8 %